Correlation between hepatocyte growth factor (HGF) and Gamma-Aminobutyric acid (GABA) plasma levels in autistic children

Biomarker Insights

Volumn 8, Issue , 2013, Pages 69-75

  Russo, Anthony J ^a  

^a HARTWICK COLLEGE   (United States)

Author keywords

Autism; GABA; HGF; Symptom severity

Indexed keywords

4 AMINOBUTYRIC ACID; SCATTER FACTOR;

AMINO ACID BLOOD LEVEL; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; MALE; ONSET AGE; PATHOGENESIS; PHOTOSENSITIVITY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TOUCH;

EID: 84879067873     PISSN: 11772719     EISSN: None     Source Type: Journal    
DOI: 10.4137/BMI.S11448     Document Type: Article

References (32)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DMS-IV-TR). American Psychiatric Association, Washington, DC, USA; 2000.
2. Petilla Interneuron Nomenclature Group, Ascoli GA, Alonso-Nanclares L, et al. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci. 2008;9(7):557-568.
3. Huang ZJ, Di Cristo G, Ango F. Development of GABA innervation in the cerebral and cerebellar cortices. Nat Rev Neurosci. 2007;8(9):673-686.
4. Miles R, Tóth K, Gulyás AI, Hájos N, Freund TF. Differences between somatic and dendritic inhibition in the hippocampus. Neuron. 1996;16(4):815-823.
5. Somogyi P, Klausberger T. Defined types of cortical interneurone structure space and spike timing in the hippocampus. J Physiol. 2005;562(Pt 1): 9-26.
6. Owens DF, Kriegstein AR. Is there more to GABA than synaptic inhibition? Nat Rev Neurosci. 2002;3(9):715-27.
7. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci U S A. 1986;83(17):6489-6493.
8. Nakamura T., Nawa K, Ichihara A. Partial purification and characterization in hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984;122(3):1450-1459.
9. Sasaki M, Nishio M, Sasaki T, Enami J. Identification of mouse mammary fibroblast-derived mammary growth factor as hepatocyte growth factor. Biochem Biophys Res Commun. 1994;199(2):772-779.
10. Michalopoulos G, Houck KA, Dolan ML, Leutteke NC. Control of hepatocyte replication by two serum factors. Cancer Res. 1984;44(10):4414-9.
11. Thaler FJ, Michalopoulos G. Hepatopoietin A: partial characterization and trypsin activation of a hepatocyte growth factor. Cancer Res. 1985;45(6):2545-2249.
12. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol. 1995;129(5):1177-1180.
13. Weidner KM, Arakaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A. 1991;88(16):7001-7005.
14. Comoglio PM, Graziani A. Guidebook to Cytokines and their Receptors, Nicola NA, editor. Oxford University Press; 1994:182.
15. Comoglio PM, Graziani A. Guidebook to Cytokines and their Receptors, Nicola NA, editor. Oxford University Press; 1994:185.
16. Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993;90(5):1937-1941.
17. Hamanoue M, Takemoto N, Matsumoto K, Nakamura T, Nakajima K, Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res. 1996;43(5):554-564.
18. Zachmann M, Tocci P, Nyhan WL. The occurrence of gamma-aminobutyric acid in human tissues other than brain. J Biol Chem. 1966;241(6):1355-1358.
19. Bae MH, Bissonette GB, Mars WM, et al. Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility. Exp Neurol. 2010;221(1):129-135.
20. Akimoto M, Baba A, Ikeda-Matsuo Y, et al. Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus. Neuroscience. 2004;128(1):155-162.
21. Powell EM, Campbell DB, Stanwood GD, Davis C, Noebels JL, Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci. 2003;23(2):622-631.
22. Levitt P, Eagleson KL, Powell EM. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci. 2004;27(7):400-406.
23. Powell EM, Mars WM, Levitt P. Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron. 2001;30(1):79-89.
24. Jackson PB, Boccuto L, Skinner C, et al. Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder. Autism Res. 2009;2(4):232-236.
25. Campbell DB, Sutcliffe JS, Ebert PJ, et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A. 2006;103(45):16834-16839.
26. Martins GJ, Shahrokh M, Powell EM. Genetic disruption of Met signaling impairs GABAergic striatal development and cognition. Neuroscience. 2010;176:199-209.
27. Russo AJ, Krigsman A, Jepson B, Wakefield A. Decreased serum hepatocyte growth factor (HGF) in autistic children with severe gastrointestinal disease. Biomark Insights. 2009;4:181-190.
28. Dhossche D, Applegate H, Abraham A, et al. Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism. Med Sci Monit. 2002;8(8):1-6.
29. Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord. 2001;31(6):537-543.
30. Rolf LH, Haarmann FY, Grotemeyer KH, Kehrer H. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand. 1993;87(5):312-316.
31. Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry. 2002;52(8):805-810.
32. Rout UK, Dhossche DM. A pathogenetic model of autism involving Purkinje cell loss through anti-GAD antibodies. Med Hypotheses. 2008;71(2):218-221.